Effect of a Therapeutic Maximum Allowable Cost (MAC) Program on the Cost and Utilization of Proton Pump Inhibitors in an Employer-Sponsored Drug Plan in Canada

BACKGROUND: Therapeutic maximum allowable cost (MAC) is a managed care intervention that uses reference pricing in a therapeutic class or category of drugs or an indication (e.g., heartburn). Therapeutic MAC has not been studied in Canada or the United States. The proton pump inhibitor (PPI) rabepra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mabasa, Vincent, Ma, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437583/
https://www.ncbi.nlm.nih.gov/pubmed/16792443
http://dx.doi.org/10.18553/jmcp.2006.12.5.371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437583/
https://www.ncbi.nlm.nih.gov/pubmed/16792443
http://dx.doi.org/10.18553/jmcp.2006.12.5.371

Ejemplares similares